Home > Insider Trading > Filing (0000950170-24-135796)

Filing Details

Accession Number:: 0000950170-24-135796
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-12-12 16:15:06
Reporting Period:: 2024-12-10

Accepted Time:: 2024-12-12 16:15:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1936258	Newamsterdam Pharma Co N.v.	NAMS	()	P7

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1823747	U.a. Cooperatief Iv Fund Capital Forbion	C/O Forbion Capital Partners, Gooimeer 2-35 Narden P7 1411 DC	No	No	No	No
1911047	U.a. Cooperatief I Fund Opportunities Growth Forbion	C/O Forbion Capital Partners, Gooimeer 2-35 Narden P7 1411 DC	No	No	No	No
1918318	B.v. Management Growth Forbion	C/O Forbion Capital Partners, Gooimeer 2-35 Narden P7 1411 DC	No	No	No	No
2005384	B.v. Management Iv Forbion	C/O Forbion Capital Partners, Gooimeer 2-35 Narden P7 1411 DC	No	No	No	No
2005407	B.v. Nap Forgrowth	C/O Forbion Capital Partners, Gooimeer 2-35, Naarden P7 1411 DC	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2024-12-10	259,739	$25.22	11,519,021	No	4	S	Indirect	See footnote
Ordinary Shares	Disposition	2024-12-10	48,511	$26.15	11,470,510	No	4	S	Indirect	See footnote
Ordinary Shares	Disposition	2024-12-11	130,561	$25.26	11,339,949	No	4	S	Indirect	See footnote
Ordinary Shares	Disposition	2024-12-11	18,583	$26.41	11,321,366	No	4	S	Indirect	See footnote
Ordinary Shares	Disposition	2024-12-11	4,894	$27.11	11,316,472	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by NAP PoolCo B.V. ("PoolCo") on March 28, 2024.
Represents 114,077 shares sold on behalf of Forbion Growth Opportunities Fund I Cooperatief U.A. ("Forbion Growth I") and 145,662 shares sold on behalf of Forbion Capital Fund IV Cooperatief U.A. ("Forbion IV"). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.99. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,519,021 Ordinary Shares beneficially owned by ForGrowth NAP B.V. ("ForGrowth"), 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,866,848 are held by PoolCo and are allocated to ForGrowth,
(Continued from footnote 2) of which 4,406,674 shares are beneficially owned by Forbion Growth I and 6,460,174 shares are beneficially owned by Forbion IV.
ForGrowth is a shareholder of PoolCo. ForGrowth is a joint investment vehicle wholly owned by Forbion Growth I and Forbion IV but does not exercise voting or dispositive power over the Ordinary Shares held on behalf of Forbion Growth I and Forbion IV. Forbion IV Management B.V. is the sole director of Forbion IV and Forbion Growth Management B.V. is the sole director of Forbion Growth I. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose.
Represents 21,306 shares sold on behalf of Forbion Growth I and 27,205 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.00 to $26.33. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,470,510 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,818,337 are held by PoolCo and are allocated to ForGrowth, of which 4,385,368 shares are beneficially owned by Forbion Growth I and 6,432,969 shares are beneficially owned by Forbion IV.
Represents 57,342 shares sold on behalf of Forbion Growth I and 73,219 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $25.00 to $25.995. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,339,949 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,687,776 are held by PoolCo and are allocated to ForGrowth, of which 4,328,026 shares are beneficially owned by Forbion Growth I and 6,359,750 shares are beneficially owned by Forbion IV.
Represents 8,162 shares sold on behalf of Forbion Growth I and 10,421 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $26.00 to $26.80. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,321,366 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,669,193 are held by PoolCo and are allocated to ForGrowth, of which 4,319,864 shares are beneficially owned by Forbion Growth I and 6,349,329 shares are beneficially owned by Forbion IV.
Represents 2,149 shares sold on behalf of Forbion Growth I and 2,745 shares sold on behalf of Forbion IV. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $27.09 to $27.21. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Following the reported transaction, of the 11,316,472 Ordinary Shares beneficially owned by ForGrowth, 652,173 shares are directly owned by ForGrowth on behalf of Forbion Growth I, and 10,664,299 are held by PoolCo and are allocated to ForGrowth, of which 4,317,715 shares are beneficially owned by Forbion Growth I and 6,346,584 shares are beneficially owned by Forbion IV.